Mapping Non-response in a Prevention Program for Cardiometabolic Diseases in Primary Care: How to Improve Participation?
Overview
Authors
Affiliations
Non-response in prevention programs for cardiometabolic diseases (CMD) in primary care is often overlooked. The aim for this study was to define factors that influence the primary response to a selective CMD prevention program and to determine response-enhancing strategies that influence the willingness to participate. We conducted a non-response analysis within a randomized controlled trial evaluating a selective CMD prevention program, the study was conducted from 2013 to 2018 in Netherlands. A random sample of 5616 patients from 15 general practices were invited to complete a risk score (RS) as initial step of the program. Non-responders received an additional questionnaire. The response on the risk score was 51% (n = 2872). From the 3558 non-response questionnaires sent, 786 (22%) were returned. In a multivariable multilevel regression analysis smoking was independently associated with non-response. Of all reported reasons for non-response 'forgot/no time' accounted for 45%. In total, 73% of the non-responders indicated to reconsider participation when approached differently. A personal approach by the patients' own GP, using advertisements and informative campaigns are potentially the best methods to enhance the response. Although a relatively high proportion did not respond to the invitation for the risk score, the majority of them indicated to be willing to participate if a different invitation strategy would be used. With more time and energy, response rates for CMD prevention programs could possibly increase substantially. A next logical step in this process is to test potential response enhancing strategies in research setting.
Smits G, van Doorn S, Bots M, Hollander M BMC Prim Care. 2024; 25(1):55.
PMID: 38342918 PMC: 10860257. DOI: 10.1186/s12875-024-02293-9.
Zondag A, Groenhof T, van der Graaf R, van Solinge W, Bots M, Haitjema S BMC Med Res Methodol. 2023; 23(1):98.
PMID: 37087415 PMC: 10122202. DOI: 10.1186/s12874-023-01924-6.
Czwikla J, Herzberg A, Kapp S, Kloep S, Rothgang H, Nitschke I Trials. 2022; 23(1):560.
PMID: 35804423 PMC: 9264743. DOI: 10.1186/s13063-022-06470-y.
Leick C, Larsen L, Larrabee Sonderlund A, Svensson N, Sondergaard J, Thilsing T BMC Public Health. 2022; 22(1):970.
PMID: 35562735 PMC: 9107116. DOI: 10.1186/s12889-022-13382-8.
de Boer A, Hollander M, van Dis I, Visseren F, Bots M, Vaartjes I BJGP Open. 2021; 6(2).
PMID: 34862163 PMC: 9447314. DOI: 10.3399/BJGPO.2021.0131.